This information is intended
for U.S. Healthcare Professionals only

Please verify that you are a U.S. Healthcare Professional

I am not a U.S. Healthcare Professional
Return
 I am a U.S. Healthcare Professional
Continue

Mark W. Clemens, MD • Houston, Texas

TRAM flap donor site reinforcement using SERI® Surgical Scaffold for soft tissue support

Postoperative care and follow-up

Lovenox® (low-molecular-weight heparin) was administered during the patient’s hospital stay, starting on postoperative day 1. She was discharged from the hospital 4 days after the initial surgery. Both at discharge and postoperatively, there was no palpability of SERI® Surgical Scaffold. The patient was instructed to start walking as soon as possible and to avoid lifting for 6 weeks. The drains were removed at 23 days after surgery. She had good pain control and no postoperative complications.

Results

At 8 months, her abdominal contour was improved and she had no evidence of hernia, bulge, or abdominal asymmetry.

Before use of SERI® Surgical Scaffold

After use of SERI® Surgical Scaffold at 25 months

Actual patient photos. Individual results may vary.

Summary

Dr. Clemens reported that SERI® Surgical Scaffold felt soft and pliable, yet strong enough to support the abdominal wall closure. He found the weave of SERI® Surgical Scaffold easy to manipulate and that it enabled clear visualization throughout the procedure, without moving, while being sutured to the abdominal wall. The weave also allowed for transmission of fluids, which helped to prevent fluid buildup.

This Case Review is provided for your information only. As with other surgical and medical decisions, it is the responsibility of surgeons to use sound medical judgment in utilizing the procedures best suited to the needs of each patient and to the skills and experiences of the surgeon. Please refer to the SERI® Surgical Scaffold Instructions for Use for current information.

Bioreplaced
Over Time1,*
Learn more
Frequently Asked
Questions
Get answers to
your questions
Support and Strength
from Native Tissue1,*
Learn more
Case
Reviews
See operative
techniques using SERI®

Indications for Use
SERI® Surgical Scaffold is indicated for use as a transitory scaffold for soft tissue support and repair to reinforce deficiencies where weakness or voids exist that require the addition of material to obtain the desired surgical outcome. This includes reinforcement of soft tissue in plastic and reconstructive surgery, and general soft tissue reconstruction.

Important Safety Information

Contraindications

  • Patients with a known allergy to silk
  • Contraindicated for direct contact with bowel or viscera where formation of adhesions may occur

Warnings

  • SERI® Surgical Scaffold must be placed in maximum possible contact with healthy well-vascularized tissue to encourage ingrowth and tissue remodeling
  • Caution should be used when implanting SERI® Surgical Scaffold in pregnant women. The use of a device that can impede tissue expansion may be hazardous during pregnancy

Adverse Reactions
Adverse reactions are those typically associated with surgically implantable materials, including infection, inflammation, adhesion formation, fistula formation, and extrusion.